Insight into the role of DL-α-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments

Molecular and Cellular Biochemistry

Volumn 289, Issue 1-2, 2006, Pages 31-37

  Mythili, Y ^a   Sudharsan, P T ^a   Varalakshmi, P ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Cyclophosphamide; Heart; Lipoic acid; Myofibrillar calcium sensitivity; Ultrastructure

Indexed keywords

CALCIUM ION; CYCLOPHOSPHAMIDE; EDETIC ACID; MYOSIN ADENOSINE TRIPHOSPHATASE; POTASSIUM ION; THIOCTIC ACID; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CELL ISOLATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART FUNCTION; HEART MUSCLE CELL; MALE; MYOFILAMENT; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CALCIUM; CYCLOPHOSPHAMIDE; MALE; MICROFILAMENTS; MYOCARDIUM; MYOSINS; RATS; RATS, WISTAR; THIOCTIC ACID; TROPONIN I;

RATTUS NORVEGICUS;

EID: 33748304119     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9144-4     Document Type: Article

References (31)

1. Dollery C: Cyclophosphamide. In: Dollery C (ed)., Therapeutic Drugs. Churchill Livingstone, Edinburg, pp. 349-353, 1999
2. Shanholtz C: Acute life-threatening toxicity of cancer treatment. Crit Care Clin 17: 483-502, 2001
3. Giordano FJ: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115: 500-508, 2005
4. Hajjar RJ, Schwinger RH, Schmidt U, Kim CS, Lebeche D, Doye AA, Gwathmey JK: Myofilament calcium regulation in human myocardium. Circulation 101: 1679-1685, 2000
5. Kagan VE, Shvedova A, Serbinova E, Khan S, Swanson C, Powell R, Packer L: Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. Biochem Pharmacol 44: 1637-1649, 1992
6. Packer L, Witt EH, Tritschler HJ: Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19: 227-250, 1995
7. Freisleben HJ: Lipoic acid reduces ischemia-reperfusion injury in animal models. Toxicology 148: 159-171, 2000
8. Vasdev S, Longerich L, Singal P: Nutrition and hypertension. Nutr Res 22: 111-123, 2002
9. Bodor GS, Porter S, Landt Y, Ladenson JH: Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 38: 2203-2214, 1992
10. Solaro RJ, Pang DC, Briggs FN: The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta 245: 259-262, 1971
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
12. 2+ binding to troponin C. Am J Physiol 268: C1348-1353, 1995
13. Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 66: 375-400, 1925
14. Gharib MI, Burnett AK: Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis. Eur J Heart Fail 4: 235-242, 2002
15. Lee CK, Harman GS, Hohl RJ, Gingrich RD: Fatal cyclophosphamide cardiomyopathy: Its clinical course and treatment. Bone Marrow Transplant 18: 573-577, 1996
16. Appelbaum F, Strauchen JA, Graw RG Jr, Savage DD, Kent KM, Ferrans VJ, Herzig GP: Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet 1: 58-62, 1976
17. Mair J, Puschendorf B, Michel G: Clinical significance of cardiac contractile proteins for the diagnosis of myocardial injury. Adv Clin Chem 31: 63-98, 1994
18. Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K, Lovgren T, Bulargina TV, Trifonov IR, Gratsiansky NA, Pulkki K, Voipio-Pulkki LM, Gusev NB: Degradation of cardiac troponin I: Implication for reliable immunodetection. Clin Chem 44: 2433-2440, 1998
19. Schonheit K, Gille L, Nohl H: Effect of alpha-lipoic acid and dihydrolipoic acid on ischemia/reperfusion injury of the heart and heart mitochondria. Biochim Biophys Acta 1271: 335-342, 1995
20. de Tombe PP: Altered contractile function in heart failure. Cardiovasc Res 37: 367-380, 1998
21. Suzuki S, Kaneko M, Chapman DC, Dhalla NS: Alterations in cardiac contractile proteins due to oxygen free radicals. Biochim Biophys Acta 1074: 95-100, 1991
22. Solaro RJ: Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res 84: 122-124, 1999
23. Marston SB, Redwood CS: Modulation of thin filament activation by breakdown or isoform switching of thin filament proteins: Physiological and pathological implications. Circ Res 93: 1170-1178, 2003
24. Jezernik K, Romih R, Mannherz HG, Koprivec D: Immunohistochemical detection of apoptosis, proliferation and inducible nitric oxide synthase in rat urothelium damaged by cyclophosphamide treatment. Cell Biol Int 27: 863-869, 2003
25. Communal C, Sumandea M, de Tombe P, Narula J, Solaro RJ, Hajjar RJ: Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A 99: 6252-6256, 2002
26. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E: Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80: 393-399, 1997
27. Matsumura Y, Saeki E, Inoue M, Hori M, Kamada T, Kusuoka H: Inhomogeneous disappearance of myofilament-related cytoskeletal proteins in stunned myocardium of guinea pig. Circ Res 79: 447-454, 1996
28. Solaro RJ, Van Eyk J: Altered interactions among thin filament proteins modulate cardiac function. J Mol Cell Cardiol 28: 217-230, 1996
29. Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P: Protective effect of DL-α- lipoic acid on cyclophosphamide induced oxidative cardiac injury. Chem Biol Interact 151: 13-19, 2004
30. Mythili Y, Sudharsan PT, Varalakshmi P: Cytoprotective role of DL-α-lipoic acid on cyclophosphamide induced myocardial toxicity. Mol Cell Biochem 276: 39-44, 2005
31. Wutzen J: Histological and histochemical examinations of the myocardium of rats kept on low-magnesium diet and treated with cyclophosphamide. Mater Med Pol 22: 162-167, 1990